Skip to main content
Premium Trial:

Request an Annual Quote

ReadCoor Wins $2.5M Gates Grant for FISSEQ Pathogen Detection Technology

NEW YORK (GenomeWeb) ­– Sequencing platform developer ReadCoor has been awarded a $2.5 million, two-year grant from the Bill and Melinda Gates Foundation to develop the infectious disease detection capabilities of its tissue-based fluorescent in situ sequencing (FISSEQ ) technology.

The Gates funding will support development of FISSEQ-based diagnostics and analytical tools specifically targeting pathogens associated with early childhood diseases and epidemics, the firm said. An aim of ReadCoor's in situ approach is also to create a disease atlas based on FISSEQ's comprehensive view of interactions between cells and tissues.

"We are committed to applying the FISSEQ platform for the benefit of humankind and we applaud the Gates Foundation for its vision and willingness to support innovative approaches to age-old problems," ReadCoor Co-Founder and CEO Shawn Marcell said in a statement.

A spinout of the Wyss Institute for Biologically Inspired Engineering at Harvard University, the firm raised $23 million in Series A funding earlier this year. ReadCoor has said it will offer the proprietary FISSEQ technology as a service, and plans to develop a platform for in situ sequencing.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.